BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

22 related articles for article (PubMed ID: 15886845)

  • 1. Immunohistochemical expression of COX-2, Ki-67, Bcl-2, Bax, VEGF and CD105 according to histological grading in oral squamous cell carcinoma.
    Escobar E; Gómez-Valenzuela F; Peñafiel C; Hormazábal-Hevia A; Herrera-Fuentes C; Mori-Aliaga D
    Rev Esp Patol; 2023; 56(3):147-157. PubMed ID: 37419553
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oral erythroplakia harbouring a squamous cell carcinoma.
    Das R; Misra SR; Baskaran P; Mohanty N
    BMJ Case Rep; 2022 Feb; 15(2):. PubMed ID: 35131799
    [No Abstract]   [Full Text] [Related]  

  • 3. Expression of VEGF and Cox-2 in Patients with Esophageal Squamous Cell Carcinoma.
    Luz CCF; Noguti J; Araújo L; Simão Gomes T; Mara G; Silva MS; Artigiani Neto R
    Asian Pac J Cancer Prev; 2018 Jan; 19(1):171-177. PubMed ID: 29373910
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of cyclooxygenase 2 in oral submucous fibrosis: An immunohistochemical pilot study.
    Rangaswamy S; Chikkalingaiah RG; Sharada P; Kumar VK
    J Oral Maxillofac Pathol; 2019; 23(2):301. PubMed ID: 31516243
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oral epithelial dysplasia: Classifications and clinical relevance in risk assessment of oral potentially malignant disorders.
    Ranganathan K; Kavitha L
    J Oral Maxillofac Pathol; 2019; 23(1):19-27. PubMed ID: 31110412
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunohistochemically Detection of Angiogenesis in Oral Pre-Cancerous Lesions Compared with Oral Invasive Carcinomas.
    Kargahi N; Torabinia N; Razavi SM; Tahririan D; Kamani H; Nazari M
    Asian Pac J Cancer Prev; 2018 Jul; 19(7):1805-1808. PubMed ID: 30049191
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytokines secreted by inflamed oral mucosa: implications for oral cancer progression.
    Danella EB; Costa de Medeiros M; D'Silva NJ
    Oncogene; 2023 Apr; 42(15):1159-1165. PubMed ID: 36879116
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential immunohistochemical expression profiles of perlecan-binding growth factors in epithelial dysplasia, carcinoma in situ, and squamous cell carcinoma of the oral mucosa.
    Hasegawa M; Cheng J; Maruyama S; Yamazaki M; Abé T; Babkair H; Saito C; Saku T
    Pathol Res Pract; 2016 May; 212(5):426-36. PubMed ID: 26965914
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunohistochemical study of p21 and Bcl-2 in leukoplakia, oral submucous fibrosis and oral squamous cell carcinoma.
    Sutariya RV; Manjunatha BS
    J Exp Ther Oncol; 2016 Nov; 11(4):285-292. PubMed ID: 27849339
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of vascular endothelial growth factor (VEGF) in normal oral mucosa, oral dysplasia and oral squamous cell carcinoma.
    Johnstone S; Logan RM
    Int J Oral Maxillofac Surg; 2007 Mar; 36(3):263-6. PubMed ID: 17141472
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stromelysin 3, Ets-1, and vascular endothelial growth factor expression in oral precancerous and cancerous lesions: correlation with microvessel density, progression, and prognosis.
    Arora S; Kaur J; Sharma C; Mathur M; Bahadur S; Shukla NK; Deo SV; Ralhan R
    Clin Cancer Res; 2005 Mar; 11(6):2272-84. PubMed ID: 15788677
    [TBL] [Abstract][Full Text] [Related]  

  • 12. p73 expression for human buccal epithelial dysplasia and squamous cell carcinoma: does it correlate with nodal status of carcinoma and is there a relationship with malignant change of epithelial dysplasia?
    Chen YK; Hsue SS; Lin LM
    Head Neck; 2004 Nov; 26(11):945-52. PubMed ID: 15390192
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The expressions of cyclooxygenase-2 (Cox-2),VEGF in oral squamous cell carcinoma and precancerous lesions and their significances].
    Sun XJ; Ma J; Zhang H; Wang XK; Li JH
    Shanghai Kou Qiang Yi Xue; 2005 Apr; 14(2):173-6. PubMed ID: 15886845
    [TBL] [Abstract][Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.